German Chemical Industry RadarJuly 2026

Tracking the Transformation

Monthly intelligence briefings on Germany's chemical and pharmaceutical sector—tracking structural shifts, corporate strategy, and the energy transition impact.

10 Editions
Mood: 3.2/10
Updated Monthly

Current State (July 2026)

Current Mood

3.2/10
+0.6 vs prev

H1 production

−3% y/y
No chemical and pharmaceutical volume recovery

German power

€105.49/MWh
Down month on month, still 20.1% above July 2025

Capex moving abroad

43%
Some or significant relocation reported

Monthly Radar

Deep-dive strategic analysis · Structural outlook

Mood Index Trend

Scale: 1-10
2468103.02.52.32.83.11.81.71.62.63.2Nov 25Dec 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26

The Radar

July

VCI ruled out a sustainable recovery

Production fell and the full-year forecast remained negative.

July

BASF raised its EBITDA outlook

Operating improvement and the Coatings disposal lifted the year.

July

Wacker raised its earnings range

Savings and pricing worked without reversing German job reductions.

June

Evonik cut 3,200 more jobs

About 2,150 reductions were assigned to Germany; Witten will close.

June

Merck agreed to acquire Bio-Techne

An $11.3 billion shift toward global life-science tools.

June

Bayer won a landmark Roundup case

The Supreme Court decision drove an exceptional equity re-rating.

Monthly Editions

View Archive

Read the Latest Report

Earnings relief was real; a German chemical recovery was not. Corporate results improved while outpu...

Read July 2026